ENDRA Life Sciences (NDRA) Asset Writedowns and Impairment (2018 - 2019)
Historic Asset Writedowns and Impairment for ENDRA Life Sciences (NDRA) over the last 2 years, with Q4 2019 value amounting to $249256.0.
- ENDRA Life Sciences' Asset Writedowns and Impairment changed N/A to $249256.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $536797.0, marking a year-over-year increase of 8668.54%. This contributed to the annual value of $249256.0 for FY2019, which is 1331.46% down from last year.
- Per ENDRA Life Sciences' latest filing, its Asset Writedowns and Impairment stood at $249256.0 for Q4 2019.
- In the past 5 years, ENDRA Life Sciences' Asset Writedowns and Impairment registered a high of $287541.0 during Q3 2018, and its lowest value of $249256.0 during Q4 2019.